Oxeia Biopharmaceuticals

View Original

Roll Call: Concussions and First Responders

Writing in support of the TBI and PTSD Law Enforcement Training Act, Dr.Michael Wyand, CEO of Oxeia Biopharmaceuticals, calls for adding funding to the bill for finding an effective treatment for concussion.